HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Angels Garcia-Cazorla Selected Research
Angels Garcia-Cazorla Research Topics
Disease
2
Brain Diseases (Brain Disorder)
09/2013 - 02/2008
2
Mitochondrial Diseases (Mitochondrial Disease)
11/2011 - 06/2008
1
Bacterial Infections (Bacterial Infection)
10/2020
1
Neuroinflammatory Diseases
10/2020
1
Phenylketonurias (Phenylketonuria)
11/2017
1
due to Sepiapterin Reductase Deficiency Dopa-Responsive Dystonia
11/2017
1
Aromatic amino acid decarboxylase deficiency
11/2017
1
Inborn Genetic Diseases (Disease, Hereditary)
11/2017
1
Ornithine Carbamoyltransferase Deficiency Disease
03/2016
1
Nervous System Diseases (Neurological Disorders)
01/2016
1
Leigh Disease (Leigh's Disease)
01/2016
1
MELAS Syndrome (Syndrome, MELAS)
06/2012
1
Cognitive Dysfunction
06/2012
1
Chorea (Rheumatic Chorea)
03/2012
1
AIDS-Related Complex (ARC)
02/2009
1
Partial Epilepsies (Epilepsy, Partial)
02/2008
1
Infantile Spasms (West Syndrome)
02/2008
1
Failure to Thrive
02/2005
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
10/2020 - 02/2009
2
Neopterin
IBA
10/2020 - 02/2008
2
Biomarkers (Surrogate Marker)
IBA
10/2020 - 01/2016
2
Neurotransmitter Agents (Neurotransmitter)
IBA
06/2008 - 02/2008
1
Guanosine Triphosphate (GTP)
IBA
11/2017
1
Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
IBA
11/2017
1
6-pyruvoyltetrahydropterin synthase (PTPS)
IBA
11/2017
1
Serotonin (5 Hydroxytryptamine)
IBA
11/2017
1
A-factor (Streptomyces)
IBA
03/2016
1
Biotin (Vitamin H)
FDA Link
01/2016
1
Thiamine (Aneurin)
FDA Link
01/2016
1
Thioctic Acid (Lipoic Acid)
IBA
09/2013
1
Calbindin 1
IBA
06/2012
1
Calcium-Binding Proteins
IBA
06/2012
1
Calbindins
IBA
06/2012
1
Levodopa (L Dopa)
FDA Link
Generic
03/2012
1
Messenger RNA (mRNA)
IBA
02/2009
1
Biopterins
IBA
02/2008
1
Biogenic Amines (Biogenic Amine)
IBA
02/2008
1
Acids
IBA
02/2008
1
Pterins
IBA
02/2008
1
Congenital disorder of glycosylation type 1A
IBA
02/2005